Beck Capital Management, LLC Abb Vie Inc. Transaction History

Beck Capital Management, LLC

$329 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $2,458 - $2,831	17 Added 0.09%	19,567 $3.12 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $40,524 - $48,599	-293 Reduced 1.48%	19,550 $3.16 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.18 Million - $1.35 Million	-8,791 Reduced 30.7%	19,843 $2.66 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $201,475 - $256,141	-1,464 Reduced 4.86%	28,634 $4.39 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $2.01 Million - $2.49 Million	15,206 Added 102.11%	30,098 $4.88 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $98,191 - $124,240	914 Added 6.54%	14,892 $2.02 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $138,639 - $157,376	1,303 Added 10.28%	13,978 $1.51 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $20,305 - $22,621	-193 Reduced 1.5%	12,675 $1.43 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $47,569 - $52,368	465 Added 3.75%	12,868 $1.39 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $998,317 - $1.35 Million	12,403 New	12,403 $1.33 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $3.61 Million - $4.02 Million	-40,651 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $92,293 - $109,204	-1,028 Reduced 2.47%	40,651 $3.77 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $352,214 - $471,647	3,828 Added 10.11%	41,679 $3.95 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $226,139 - $247,980	2,525 Added 7.15%	37,851 $3.66 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.8 Million - $2.3 Million	25,824 Added 271.77%	35,326 $3.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	9,502	9,502 $691,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beck Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beck Capital Management, LLC with notifications on news.

Account